186 related articles for article (PubMed ID: 14959696)
1. Weight loss, wasting, and survival in HIV-positive patients: current strategies.
Tang AM
AIDS Read; 2003 Dec; 13(12 Suppl):S23-7. PubMed ID: 14959696
[TBL] [Abstract][Full Text] [Related]
2. Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort.
Mangili A; Murman DH; Zampini AM; Wanke CA
Clin Infect Dis; 2006 Mar; 42(6):836-42. PubMed ID: 16477562
[TBL] [Abstract][Full Text] [Related]
3. HIV-associated wasting in the era of HAART: a practice-based approach to diagnosis and treatment.
Steinhart CR
AIDS Read; 2001 Nov; 11(11):557-60, 566-9. PubMed ID: 11789018
[TBL] [Abstract][Full Text] [Related]
4. Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy.
Wanke CA; Silva M; Knox TA; Forrester J; Speigelman D; Gorbach SL
Clin Infect Dis; 2000 Sep; 31(3):803-5. PubMed ID: 11017833
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and predictors of HIV-associated weight loss in the era of highly active antiretroviral therapy.
Batterham MJ; Garsia R; Greenop P
Int J STD AIDS; 2002 Nov; 13(11):744-7. PubMed ID: 12437893
[TBL] [Abstract][Full Text] [Related]
6. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
Gold J; Batterham MJ; Rekers H; Harms MK; Geurts TB; Helmyr PM; Silva de Mendonça J; Falleiros Carvalho LH; Panos G; Pinchera A; Aiuti F; Lee C; Horban A; Gatell J; Phanuphak P; Prasithsirikul W; Gazzard B; Bloch M; Danner SA;
HIV Med; 2006 Apr; 7(3):146-55. PubMed ID: 16494628
[TBL] [Abstract][Full Text] [Related]
7. Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy.
Tang AM; Forrester J; Spiegelman D; Knox TA; Tchetgen E; Gorbach SL
J Acquir Immune Defic Syndr; 2002 Oct; 31(2):230-6. PubMed ID: 12394802
[TBL] [Abstract][Full Text] [Related]
8. Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
Mulligan K; Zackin R; Clark RA; Alston-Smith B; Liu T; Sattler FR; Delvers TB; Currier JS; ;
Arch Intern Med; 2005 Mar; 165(5):578-85. PubMed ID: 15767536
[TBL] [Abstract][Full Text] [Related]
9. Acquired immunodeficiency syndrome wasting, functional performance, and quality of life.
Roubenoff R
Am J Manag Care; 2000 Sep; 6(9):1003-16. PubMed ID: 11184062
[TBL] [Abstract][Full Text] [Related]
10. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy.
Wexler A; Berson AM; Goldstone SE; Waltzman R; Penzer J; Maisonet OG; McDermott B; Rescigno J
Dis Colon Rectum; 2008 Jan; 51(1):73-81. PubMed ID: 18066626
[TBL] [Abstract][Full Text] [Related]
11. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment.
Gelato M; McNurlan M; Freedland E
Clin Ther; 2007 Nov; 29(11):2269-88. PubMed ID: 18158071
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of body morphology changes and lipid abnormalities associated with HIV Infection and its therapies.
Wohl DA
Top HIV Med; 2004; 12(3):89-93. PubMed ID: 15310940
[TBL] [Abstract][Full Text] [Related]
13. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study.
Brown TT; Cole SR; Li X; Kingsley LA; Palella FJ; Riddler SA; Visscher BR; Margolick JB; Dobs AS
Arch Intern Med; 2005 May; 165(10):1179-84. PubMed ID: 15911733
[TBL] [Abstract][Full Text] [Related]
15. Body shape and composition in HIV-infected women: an urban cohort.
Karmon SL; Moore RD; Dobs AS; Keruly J; Barnett S; Cofrancesco J
HIV Med; 2005 Jul; 6(4):245-52. PubMed ID: 16011529
[TBL] [Abstract][Full Text] [Related]
16. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
17. Effect of recombinant human growth hormone on exercise capacity in patients with HIV-associated wasting on HAART.
Evans WJ; Kotler DP; Staszewski S; Griffin GE; Isgaard J; Gertner JM; O'Brien F; Svanberg E
AIDS Read; 2005 Jun; 15(6):301-3, 306-8, 310, 314. PubMed ID: 15962453
[TBL] [Abstract][Full Text] [Related]
18. [Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the highly active antiretroviral therapy (HAART)].
Pezzotti P; Dorrucci M; Donisi A; Cusini M; Mazzarello G; De Luca A; Salassa B; Ursitti MA; Giuliani M; Rezza G;
Epidemiol Prev; 2003; 27(6):348-55. PubMed ID: 15058363
[TBL] [Abstract][Full Text] [Related]
19. Evaluation and treatment of weight loss in adults with HIV disease.
Williams B; Waters D; Parker K
Am Fam Physician; 1999 Sep; 60(3):843-54, 857-60. PubMed ID: 10498111
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral therapy affects the composition of weight loss in HIV infection: implications for clinical nutrition.
Maia BS; Engelson ES; Wang J; Kotler DP
Clin Nutr; 2005 Dec; 24(6):971-8. PubMed ID: 16095765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
